In this study, we found a potential molecular mechanism of PDT for treating cSCC was that PDT inhibited MAPK activation, which was probably because the downregulation of JNK was greater than the upregulation of ERK. The gene discussed is MAPK1; the disease is skin squamous cell carcinoma.